Wall Street Analysts Predict a 75.79% Upside in Rigel (RIGL): Here's What You Should Know

Rigel Pharmaceuticals (RIGL) closed the last trading session at $17.35, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $30.50 indicates a 75.8% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $17.85. While the lowest estimate of $14 indicates a 19.3% decline from the current price level, the most optimistic analys ...